£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

Prostate Cancer Nuclear Medicine Diagnostics Outlook 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 79 days · 79 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 11 August 2026 30 August 2026 19 September 2026 08 October 2026 28 October 2026
View at Amazon ↗

Price data last checked 12 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 79 days • 1 price levels

Days at Price
79 days 0 20 40 59 79 £520 Days at Price

Price Analysis

Most common price: £520 (79 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 79 days

Description

This comprehensive study provides a detailed outlook for prostate cancer nuclear medicine diagnostics in the United States from 2023 to 2028. It focuses on latent demand, expressed in millions of U.S. dollars, which represents potential industry earnings (P.I.E.) across the country. Data is provided for approximately 12,600 cities, offering specific insights into how each location contributes to its state and the national market. By providing the percent share for each city, this report allows for quick comparative benchmarking. This statistical approach is designed to assist professionals in developing effective distribution and sales force strategies through precise market intelligence.

Key Features

Covers latent demand and potential industry earnings (P.I.E.) for prostate cancer nuclear medicine diagnostics through 2028.

Provides detailed market data across approximately 12,600 cities throughout the United States.

Includes percent share metrics for each city relative to its state and the total United States market.

Offers comparative benchmarks to help users gauge city performance against others.

Supports the development of targeted distribution and sales force strategies using statistical data.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

Prostate Cancer Nuclear Medicine Diagnostics India Outlook
99% match

Prostate Cancer Nuclear Medicine Diagnostics India Outlook

£515.00 30 Oct 2026
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in China
99% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in China

£495.00 05 Nov 2026
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in Japan
99% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in Japan

£495.00 29 Oct 2026
Prostate Cancer Nuclear Medicine Diagnostics Outlook 2025-2030
99% match

Prostate Cancer Nuclear Medicine Diagnostics Outlook 2025-2030

Price unavailable
Prostate Cancer Nuclear Medicine Diagnostics Outlook 2023-2028
98% match

Prostate Cancer Nuclear Medicine Diagnostics Outlook 2023-2028

£490.00 09 Nov 2026
Prostate Cancer Therapeutics Outlook in Japan (2016-2021)
98% match

Prostate Cancer Therapeutics Outlook in Japan (2016-2021)

£595.00 23 Sep 2026
World Outlook for Prostate Cancer Treatments 2025-2030
97% match

World Outlook for Prostate Cancer Treatments 2025-2030

Price unavailable
World Outlook for Prostate Cancer Treatments 2025-2030
97% match

World Outlook for Prostate Cancer Treatments 2025-2030

Price unavailable
Prostate Cancer Therapeutics in Africa 2013-2018 Outlook
97% match

Prostate Cancer Therapeutics in Africa 2013-2018 Outlook

£325.00 03 Sep 2026
Hormone Therapy for Prostate Cancer Outlook 2023-2028
97% match

Hormone Therapy for Prostate Cancer Outlook 2023-2028

£520.00 05 Nov 2026
Hormone Therapy for Prostate Cancer Outlook in India 2023-2028
97% match

Hormone Therapy for Prostate Cancer Outlook in India 2023-2028

£515.00 03 Nov 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in Japan
96% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in Japan

£495.00 05 Nov 2026
World Outlook for Nuclear Medicine Equipment 2025-2030
96% match

World Outlook for Nuclear Medicine Equipment 2025-2030

£790.00 08 Nov 2026
2023-2028 US Cancer Screening Outlook - Market Study
96% match

2023-2028 US Cancer Screening Outlook - Market Study

£520.00 05 Nov 2026
The 2023-2028 Outlook for Cancer Testing-Screening in the United States
96% match

The 2023-2028 Outlook for Cancer Testing-Screening in the United States

£520.00 30 Sep 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in China
96% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in China

£495.00 31 Oct 2026
US Cancer Diagnostics Lab Test Outlook 2023-2028 Study
96% match

US Cancer Diagnostics Lab Test Outlook 2023-2028 Study

£520.00 06 Nov 2026
The 2023-2028 Outlook for Cancer Testing-Screening in India
96% match

The 2023-2028 Outlook for Cancer Testing-Screening in India

£515.00 01 Oct 2026
Cancer Diagnostics Lab Test Outlook in India 2023-2028
96% match

Cancer Diagnostics Lab Test Outlook in India 2023-2028

£515.00 02 Nov 2026
US Cancer Supportive Care Outlook 2023-2028 Study Report
96% match

US Cancer Supportive Care Outlook 2023-2028 Study Report

£520.00 07 Nov 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 30 Sep 2026
Imaging and Focal Therapy of Early Prostate Cancer (Current Clinical Urology)
96% match

Imaging and Focal Therapy of Early Prostate Cancer (Current Clinical Urology)

Springer

£109.99 20 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India

£515.00 01 Oct 2026